Speaker Profile

M.D., F.A.A.D., Medical Director, Castle Biosciences

Matthew Goldberg, M.D. has served as Castle Biosciences’ Medical Director since August 2020. Prior to joining Castle, Dr. Goldberg was an Assistant Professor in Dermatology and Pathology at the Icahn School of Medicine at Mount Sinai in New York and retains his affiliation as an Assistant Clinical Professor of Dermatology. Before joining the Mount Sinai faculty, he directed Dermatopathology education for the MedStar Georgetown/Washington Hospital Center dermatology residency program. Dr. Goldberg has a background in translational melanoma research and received the Dermatology Foundation Dermatopathology Research Career Development Award for his research in the field of melanoma epigenetics.Dr. Goldberg graduated summa cum laude from Princeton University and received his medical degree from the Icahn School of Medicine at Mount Sinai. Dr. Goldberg completed his dermatology residency at the University of California, San Francisco, and completed a dermatopathology fellowship at the University of Texas Southwestern. Dr. Goldberg is board certified in dermatology and dermatopathology.

Using Molecular Diagnostics to Inform Cancer Management Decisions
Advanced approaches in molecular diagnostics can provide independent prognostic information to help clinicians make more informed decisions in the care of their patients, when limited information is available. This discussion will explore the use of genomics and spatialomics to guide personalized care in the management of skin cancers and Barrett's esophagus.

 Session Abstract – PMWC 2023 Silicon Valley

Track 3 - January 25 9.00 A.M.-4.45 P.M.

Track Chair: Hakan Sakul, Pfizer

  • PMWC Award Ceremony:
    Honoree: Todd Golub, Broad Institute
  • Fireside Chat: Precision Medicine: Past, Present and Future
    - Todd Golub, Broad Institute
    - Hakan Sakul, Pfizer
  • Challenges in Providing Global Access to Precision Health (PANEL)
    Chair: Mike Pellini, Section32
    - Peter Kuhn, USC
    - Steven Rosen
    - Sarah Hersey, BMS
    - Ed Abrahams, PMC
  • Regulatory and Reimbursement Challenges for Precision Medicines (PANEL)
    Chair: Cynthia Bens, PMC
    - Robert Dumanois, ThermoFisher
    - Kaska Kowanetz, Pfizer
    - Elaine Katrivanos, Tempus
    - Elizabeth Mansfield, Foundation Medicine
  • Early Cancer Detection 360 Degree View
    Chair: Christian Wolfrum, Siemens Healthineers
    - Stephan Brock, Molecular Health
    - Christian Eusemann, Siemens Healthineers
    - Costanzo DiPerna, CommonSpirit
  • Novel Clinical Trial Designs (PANEL)
    Chair: Razelle Kurzrock, Medical College of Wisconsin
    - Jason Sicklick, UCSD
    - Jim Palma, Target Cancer Foundation
    - Corrie Painter, Precede Bio
    - Laura J Esserman, UCSF
  • Equity in Delivery of Precision Cancer Care through Community-Academic Partnerships
    - Manali Patel, Stanford
  • Challenges in Genomic Profiling of Pediatric Cancers
    - Andrew Kung, MSK
    - Christina Curtis, Stanford
  • PMWC NCI Showcase
    - Solomon Diamond, Lodestone
    - Jennifer Smith, PreCyte
  • City of Hope Precision Medicine
    - Stephen Gruber, City of Hope
  • PMWC Showcase
    - Matthew Goldberg, Castle